New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Medtronic’s new vessel sealer, Quest’s brain infection test gain FDA market go-ahead.
You may also be interested in...
Medtronic Builds Surgical Device Offerings Via Salient, Peak Acquisitions
Medtronic will expand its energy-based surgical equipment offerings through its purchase of privately-held Salient Surgical Technologies and Peak Surgical under separate agreements valued at a combined $645 million, announced July 7.
Bridge Too Far? BMS Launch Plan For Sotyktu Pressured By Prospect Of Medicare Price Controls
With price controls in Medicare looming nine years after approval, launch strategies such as ‘bridge’ programs that build initial volume with free drug may have to be adjusted.
Are Regulators Ready For The Robot Era? ChatGPT Weighs In On EU Regulation
Artificial intelligence model’s comments signal the likely start of computer-generated comments to the US FDA’s public notices.